Cargando…

Human Recombinant ACE2 Reduces the Progression of Diabetic Nephropathy

OBJECTIVE: Diabetic nephropathy is one of the most common causes of end-stage renal failure. Inhibition of ACE2 function accelerates diabetic kidney injury, whereas renal ACE2 is downregulated in diabetic nephropathy. We examined the ability of human recombinant ACE2 (hrACE2) to slow the progression...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oudit, Gavin Y., Liu, George C., Zhong, JiuChang, Basu, Ratnadeep, Chow, Fung L., Zhou, Joyce, Loibner, Hans, Janzek, Evelyne, Schuster, Manfred, Penninger, Josef M., Herzenberg, Andrew M., Kassiri, Zamaneh, Scholey, James W.
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2809962/ https://www.ncbi.nlm.nih.gov/pubmed/19934006 http://dx.doi.org/10.2337/db09-1218

Ejemplares similares

Loss of Angiotensin-Converting Enzyme-2 Leads to the Late Development of Angiotensin II-Dependent Glomerulosclerosis
por: Oudit, Gavin Y., et al.
Publicado: (2006)

Recombinant Expression and Characterization of Human and Murine ACE2: Species-Specific Activation of the Alternative Renin-Angiotensin-System
por: Poglitsch, Marko, et al.
Publicado: (2012)

Females Are Protected From Iron‐Overload Cardiomyopathy Independent of Iron Metabolism: Key Role of Oxidative Stress
por: Das, Subhash K., et al.
Publicado: (2017)

Advanced iron-overload cardiomyopathy in a genetic murine model is rescued by resveratrol therapy
por: Das, Subhash K., et al.
Publicado: (2018)

ACE2 Deficiency Enhances Angiotensin II-Mediated Aortic Profilin-1 Expression, Inflammation and Peroxynitrite Production
por: Jin, Hai-Yan, et al.
Publicado: (2012)

Sex- and age-specific regulation of ACE2: Insights into severe COVID-19 susceptibility
por: Viveiros, Anissa, et al.
Publicado: (2022)

Apelin protects against abdominal aortic aneurysm and the therapeutic role of neutral endopeptidase resistant apelin analogs
por: Wang, Wang, et al.
Publicado: (2019)

ACE2 Deficiency Worsens Epicardial Adipose Tissue Inflammation and Cardiac Dysfunction in Response to Diet-Induced Obesity
por: Patel, Vaibhav B., et al.
Publicado: (2016)

Loss of Apelin Exacerbates Myocardial Infarction Adverse Remodeling and Ischemia‐reperfusion Injury: Therapeutic Potential of Synthetic Apelin Analogues
por: Wang, Wang, et al.
Publicado: (2013)

Long-term continuous infusion of anti-GD2 antibody CH14.18/CHO in relapsed/refractory neuroblastoma patients
por: Lode, Holger, et al.
Publicado: (2013)

Angiotensin converting enzyme 2 abrogates bleomycin-induced lung injury
por: Rey-Parra, G. J., et al.
Publicado: (2012)

Iron-overload injury and cardiomyopathy in acquired and genetic models is attenuated by resveratrol therapy
por: Das, Subhash K., et al.
Publicado: (2015)

ADAM (a Disintegrin and Metalloproteinase) 15 Deficiency Exacerbates Ang II (Angiotensin II)–Induced Aortic Remodeling Leading to Abdominal Aortic Aneurysm
por: Jana, Sayantan, et al.
Publicado: (2020)

Circulating Levels of Tumor Necrosis Factor-Alpha Receptor 2 Are Increased in Heart Failure with Preserved Ejection Fraction Relative to Heart Failure with Reduced Ejection Fraction: Evidence for a Divergence in Pathophysiology
por: Putko, Brendan N., et al.
Publicado: (2014)

Disparate Remodeling of the Extracellular Matrix and Proteoglycans in Failing Pediatric Versus Adult Hearts
por: Jana, Sayantan, et al.
Publicado: (2018)

Manipulating angiotensin metabolism with angiotensin converting enzyme 2 (ACE2) in heart failure
por: Patel, Vaibhav B., et al.
Publicado: (2012)

Biology of Tissue Inhibitor of Metalloproteinase 3 (TIMP3), and Its Therapeutic Implications in Cardiovascular Pathology
por: Fan, Dong, et al.
Publicado: (2020)

Modulation of Cardiac Fibrosis in and Beyond Cells
por: Fan, Dong, et al.
Publicado: (2021)

PI3Kα-regulated gelsolin activity is a critical determinant of cardiac cytoskeletal remodeling and heart disease
por: Patel, Vaibhav B., et al.
Publicado: (2018)

Loss of ACE2 Exacerbates Murine Renal Ischemia-Reperfusion Injury
por: Fang, Fei, et al.
Publicado: (2013)

ACE2 – From the renin–angiotensin system to gut microbiota and malnutrition
por: Perlot, Thomas, et al.
Publicado: (2013)

Transcriptomic Signatures of End-Stage Human Dilated Cardiomyopathy Hearts with and without Left Ventricular Assist Device Support
por: Parikh, Mihir, et al.
Publicado: (2022)

Angiotensin Converting Enzyme 2 - at the Heart of the COVID-19 pandemic
por: Oudit, Gavin Y., et al.
Publicado: (2023)

Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease
por: Fan, Dong, et al.
Publicado: (2012)

The Non-Fibrillar Side of Fibrosis: Contribution of the Basement Membrane, Proteoglycans, and Glycoproteins to Myocardial Fibrosis
por: Chute, Michael, et al.
Publicado: (2019)

Extracellular matrix, regional heterogeneity of the aorta, and aortic aneurysm
por: Jana, Sayantan, et al.
Publicado: (2019)

ACE polymorphism and diabetic nephropathy
por: Wiwanitkit, V.
Publicado: (2010)

Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19
por: Kuba, Keiji, et al.
Publicado: (2021)

Adoptive Transfer of siRNA Cblb-Silenced CD8(+) T Lymphocytes Augments Tumor Vaccine Efficacy in a B16 Melanoma Model
por: Hinterleitner, Reinhard, et al.
Publicado: (2012)

PI3Kα Pathway Inhibition With Doxorubicin Treatment Results in Distinct Biventricular Atrophy and Remodeling With Right Ventricular Dysfunction
por: McLean, Brent A., et al.
Publicado: (2019)

The Molecular Phenotype of Endocapillary Proliferation: Novel Therapeutic Targets for IgA Nephropathy
por: Hodgin, Jeffrey B., et al.
Publicado: (2014)

Targeting the ACE2 and Apelin Pathways Are Novel Therapies for Heart Failure: Opportunities and Challenges
por: Kazemi-Bajestani, Seyyed M. R., et al.
Publicado: (2012)

Soluble Epoxide Hydrolase in Aged Female Mice and Human Explanted Hearts Following Ischemic Injury
por: Jamieson, K. Lockhart, et al.
Publicado: (2021)

Lessons from SARS: control of acute lung failure by the SARS receptor ACE2
por: Kuba, Keiji, et al.
Publicado: (2006)

Human recombinant soluble ACE2 in severe COVID-19
por: Zoufaly, Alexander, et al.
Publicado: (2020)

The Human Explanted Heart Program: A translational bridge for cardiovascular medicine
por: Zhang, Hao, et al.
Publicado: (2021)

ACE Gene Polymorphism and renal responsiveness to ACE inhibitors in IgA nephropathy patients
por: Han, Sang Youb, et al.
Publicado: (2000)

Podocyte ACE2 protects against diabetic nephropathy
por: Harris, Raymond C.
Publicado: (2012)

Trilogy of ACE2: A peptidase in the renin–angiotensin system, a SARS receptor, and a partner for amino acid transporters
por: Kuba, Keiji, et al.
Publicado: (2010)

Association between circulating levels of ACE2-Ang-(1–7)-MAS axis and ACE2 gene polymorphisms in hypertensive patients
por: Liu, Dan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_o8i6tjliuhqhiq0go159gvoqav